鳥居薬品の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/11/15 | 2,381 | 2,406 | 2,379 | 2,393 | -12 | -0.5% | 19,300 |
2018/11/14 | 2,402 | 2,409 | 2,363 | 2,405 | +23 | +1% | 44,000 |
2018/11/13 | 2,377 | 2,402 | 2,366 | 2,382 | -9 | -0.4% | 38,100 |
2018/11/12 | 2,390 | 2,408 | 2,373 | 2,391 | -17 | -0.7% | 17,300 |
2018/11/09 | 2,419 | 2,471 | 2,407 | 2,408 | -21 | -0.9% | 25,100 |
2018/11/08 | 2,410 | 2,456 | 2,410 | 2,429 | +53 | +2.2% | 29,300 |
2018/11/07 | 2,378 | 2,408 | 2,362 | 2,376 | -6 | -0.3% | 27,600 |
2018/11/06 | 2,377 | 2,420 | 2,371 | 2,382 | +51 | +2.2% | 36,200 |
2018/11/05 | 2,331 | 2,372 | 2,296 | 2,331 | +45 | +2% | 64,300 |
2018/11/02 | 2,311 | 2,320 | 2,260 | 2,286 | -14 | -0.6% | 119,700 |
2018/11/01 | 2,637 | 2,637 | 2,300 | 2,300 | -187 | -7.5% | 128,400 |
2018/10/31 | 2,453 | 2,526 | 2,453 | 2,487 | +42 | +1.7% | 38,400 |
2018/10/30 | 2,431 | 2,482 | 2,421 | 2,445 | -11 | -0.4% | 45,100 |
2018/10/29 | 2,435 | 2,517 | 2,401 | 2,456 | +8 | +0.3% | 47,000 |
2018/10/26 | 2,442 | 2,467 | 2,400 | 2,448 | +10 | +0.4% | 61,100 |
2018/10/25 | 2,505 | 2,514 | 2,430 | 2,438 | -117 | -4.6% | 43,600 |
2018/10/24 | 2,532 | 2,562 | 2,526 | 2,555 | +24 | +0.9% | 21,400 |
2018/10/23 | 2,560 | 2,574 | 2,531 | 2,531 | -37 | -1.4% | 40,000 |
2018/10/22 | 2,567 | 2,582 | 2,542 | 2,568 | -25 | -1% | 17,000 |
2018/10/19 | 2,561 | 2,594 | 2,558 | 2,593 | ±0 | ±0% | 15,600 |
2018/10/18 | 2,579 | 2,619 | 2,578 | 2,593 | +7 | +0.3% | 32,700 |
2018/10/17 | 2,544 | 2,590 | 2,521 | 2,586 | +44 | +1.7% | 45,900 |
2018/10/16 | 2,533 | 2,555 | 2,521 | 2,542 | -12 | -0.5% | 31,200 |
2018/10/15 | 2,566 | 2,597 | 2,545 | 2,554 | -10 | -0.4% | 36,300 |
2018/10/12 | 2,565 | 2,606 | 2,544 | 2,564 | -1 | ±0% | 52,000 |
2018/10/11 | 2,555 | 2,575 | 2,510 | 2,565 | -70 | -2.7% | 74,600 |
2018/10/10 | 2,712 | 2,712 | 2,625 | 2,635 | -94 | -3.4% | 81,700 |
2018/10/09 | 2,776 | 2,776 | 2,700 | 2,729 | -59 | -2.1% | 46,000 |
2018/10/05 | 2,748 | 2,810 | 2,728 | 2,788 | +39 | +1.4% | 41,700 |
2018/10/04 | 2,740 | 2,758 | 2,709 | 2,749 | +27 | +1% | 49,900 |
2018/10/03 | 2,652 | 2,734 | 2,652 | 2,722 | +70 | +2.6% | 43,700 |
2018/10/02 | 2,667 | 2,695 | 2,643 | 2,652 | -65 | -2.4% | 65,100 |
2018/10/01 | 2,725 | 2,767 | 2,703 | 2,717 | -18 | -0.7% | 45,700 |
2018/09/28 | 2,747 | 2,787 | 2,705 | 2,735 | +16 | +0.6% | 56,600 |
2018/09/27 | 2,731 | 2,731 | 2,659 | 2,719 | -14 | -0.5% | 82,600 |
2018/09/26 | 2,741 | 2,771 | 2,700 | 2,733 | +2 | +0.1% | 40,000 |
2018/09/25 | 2,668 | 2,731 | 2,663 | 2,731 | +95 | +3.6% | 104,400 |
2018/09/21 | 2,581 | 2,650 | 2,581 | 2,636 | +46 | +1.8% | 77,100 |
2018/09/20 | 2,678 | 2,678 | 2,581 | 2,590 | -72 | -2.7% | 80,600 |
2018/09/19 | 2,709 | 2,709 | 2,648 | 2,662 | -29 | -1.1% | 100,100 |
2018/09/18 | 2,632 | 2,692 | 2,595 | 2,691 | +60 | +2.3% | 79,300 |
2018/09/14 | 2,602 | 2,673 | 2,595 | 2,631 | +55 | +2.1% | 118,200 |
2018/09/13 | 2,579 | 2,590 | 2,553 | 2,576 | +18 | +0.7% | 74,800 |
2018/09/12 | 2,471 | 2,559 | 2,454 | 2,558 | +88 | +3.6% | 118,600 |
2018/09/11 | 2,423 | 2,490 | 2,422 | 2,470 | +55 | +2.3% | 94,200 |
2018/09/10 | 2,409 | 2,420 | 2,391 | 2,415 | +6 | +0.2% | 68,300 |
2018/09/07 | 2,347 | 2,409 | 2,341 | 2,409 | +59 | +2.5% | 134,000 |
2018/09/06 | 2,342 | 2,364 | 2,331 | 2,350 | +11 | +0.5% | 49,300 |
2018/09/05 | 2,300 | 2,350 | 2,292 | 2,339 | +31 | +1.3% | 77,700 |
2018/09/04 | 2,334 | 2,336 | 2,305 | 2,308 | -23 | -1% | 85,400 |
1651~
1700
件表示中 / 3769件
類似銘柄と比較する
現在ご覧いただいている「鳥居薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.45倍 |
|
JT傘下。皮膚疾患や腎・透析、花粉症薬などアレルゲン領域に強み。塩野義製薬がTOB実施 |
ペプチド | 153,900円 | +5.0% | +1.5% | 0.00% | 13.17倍 | 3.71倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
キッセイ薬 | 429,000円 | +3.6% | - | 2.80% | 14.45倍 | 0.85倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
サンバイオ | 240,800円 | - | - | 0.00% | - | 111.54倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
科研薬 | 384,400円 | -6.4% | -71.8% | 4.94% | 42.81倍 | 0.96倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
市場注目の銘柄
チャート関連のコラム